| Dr Thomas Hagge Johnson, MD | |
|
1600 Saint Johns Blvd Ste 200, Maplewood, MN 55109-1190 | |
| (651) 326-4327 | |
| (651) 326-8171 |
| Full Name | Dr Thomas Hagge Johnson |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 40 Years |
| Location | 1600 Saint Johns Blvd Ste 200, Maplewood, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730148560 | NPI | - | NPPES |
| 277865300 | Medicaid | MN | |
| 31522300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 31296 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Healtheast St John's Hospital | Maplewood, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
| Healtheast Medical Research Institute | 3971407636 | 500 |
| Fairview Express Care | 3375645179 | 1523 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Healtheast Woodwinds Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309322 PECOS PAC ID: 9638082563 Enrollment ID: O20031107000110 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Healtheast St Joseph's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134186273 PECOS PAC ID: 2365348869 Enrollment ID: O20031208000245 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Healtheast St John's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447218482 PECOS PAC ID: 9234035742 Enrollment ID: O20031208000320 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Healtheast Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194787465 PECOS PAC ID: 7214833763 Enrollment ID: O20031208000483 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Winona Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295789352 PECOS PAC ID: 8527977420 Enrollment ID: O20040106000260 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Hagge Johnson, MD 1600 Saint Johns Blvd Ste 200, Maplewood, MN 55109-1190 Ph: (651) 236-4327 | Dr Thomas Hagge Johnson, MD 1600 Saint Johns Blvd Ste 200, Maplewood, MN 55109-1190 Ph: (651) 326-4327 |
News Archive
Sensyne Health plc, the British clinical AI technology company, today announces that it has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health's proprietary clinical AI technology platform.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Researchers in Bergen and Seattle will join forces in a project on the equitable distribution of health resources and priorities within global health. The agreement was signed during this year's Transatlantic Science Week held in Washington, D.C. in October.
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
› Verified 7 days ago
Andrzej Petryk, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1580 Beam Ave, Maplewood, MN 55109 Phone: 651-779-7978 Fax: 651-779-7656 | |
Dr. Rahul Koranne, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1575 Beam Ave, Maplewood, MN 55109 Phone: 651-232-7800 | |
Sherry A Moriarty, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1850 Beam Ave, Maplewood, MN 55109 Phone: 651-779-2500 Fax: 651-770-8834 | |
Endea J Curry, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Ovidiu George Ardeleanu, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Madison Therese Brickner, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2945 Hazelwood St Ste 100, Maplewood, MN 55109 Phone: 651-232-7800 | |
Dr. Thomas Martin Hauth, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2945 Hazelwood St, Maplewood, MN 55109 Phone: 651-232-7800 |